FIONA BRUCE MP BACKS CALL FOR WORLD-CLASS ONE-YEAR CANCER SURVIVAL RATES
Fiona Bruce MP has shown her support
for improving UK one-year survival rates while attending an All Party
Parliamentary Group on Cancer (APPGC) event in Parliament.
By 2020,
almost half of the UK population will receive a cancer diagnosis during their lifetime[i].
Cancer survival rates in the UK are among the worst in Europe – not least
because many people are diagnosed too late. The APPGC believes that this must
change.
At the event, Fiona was presented with the cancer survival rates in the
area that showed that 67% of local people with cancer will live for a year
after diagnosis. This is 2% lower than the national one-year survival rate for
England of 69%[ii]
By comparison, the one-year survival rate in Sweden is 81%.
The APPGC published a short report at
the event which highlights that from April 2015 one-year survival rates have
been included in the Delivery Dashboard of the CCG Assurance Framework – the
highest tier of accountability at a local level. This means that Clinical Commissioning Groups
are now scrutinised on what they are doing to improve earlier diagnosis in
order to improve local one-year survival rates.
Fiona also joined the APPGC which
brings together MPs and Peers from
across the political spectrum to debate key issues and campaign together to
improve cancer services.
Speaking after the event, Fiona said “The one-year cancer survival rates in the South Cheshire CCG will help
residents to see how the CCG is performing and demand improvements. As the MP, I will be meeting the CCG
leadership to discuss how, together, we can ensure more local people survive
cancer.
“In
this area only 67% of people live for a year or more after a cancer diagnosis.
In Sweden, the figure is 81%. More work is needed through earlier diagnosis to
increase this number, as the UK still has among the lowest survival rates in
Europe. Better screening uptake, diagnostics at Primary Care, public awareness
and GP training are all possible initiatives our local CCG could introduce.
Many lives each year could be saved as a result."
[i] Macmillan
estimates based on; prevalence projections to 2020 from Maddams J, Utley M,
Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br
J Cancer 2012; 107: 1195-1202. (Scenario 1); Incidence and mortality
(cancer) projections estimated to 2020 assume trends from 2000 to 2010 continue
at the same rate (except for prostate cancer where static incidence rates were
assumed from 2009 to 2030) in line with prevalence projections. 2000 to 2010
data are provided by Office for National Statistics (England); Information
Services Division (ISD) Scotland; General Registrar Office Scotland; Welsh
Cancer Intelligence & Surveillance Unit; Northern Ireland Cancer Registry;
all cause mortality projection estimates to 2030 taken from Office for National
Statistics (UK). For prostate cancer incidence projections, 2009 incidence
rates (UK) by broad age group taken from the UKCIS were applied to population
projections (UK) from Office for National Statistics to project incidence to
2030.
[ii] One-year net cancer survival index – adjusted for age, sex,
cancer type and background mortality. ONS and London School of Hygiene
and Tropical Medicine, 2013, Cancer Survival Index for Clinical Commissioning
Groups, Adults Diagnosed 1996-2011 and Followed up to 2012 (http://www.ons.gov.uk/ons/rel/cancer-unit/a-cancer-survival-index-for-clinical-commissioning-groups/adults-diagnosed-1996-2011-and-followed-up-to-2012/index.html
accessed April 2014)
[ii][ii]1 year, age adjusted
relative survival in the UK and Ireland for patients diagnosed between 2000 -
2007 is 68%, in Sweden it is 81%.
Eurocare 5 Survival Analysis 2000 – 2007 (https://w3.iss.it/site/EU5Results/ accessed January 2015)
